Myelodysplastic Syndrome Treatment in Florida

Myelodysplastic syndrome or MDS are conditions that can occur when the normally healthy blood-forming cells in the bone marrow become abnormal. When these cells become abnormal, problems arise making new blood cells. MDS is a complex condition with multiple subtypes that can affect patients in different ways.Â
Choosing a Myelodysplastic Syndrome Specialist in Florida
For about one in three patients, myelodysplastic syndrome can progress to a rapidly growing cancer of bone marrow cells called acute myeloid leukemia or AML. The Malignant Hematology Program at Moffitt has one of the largest MDS treatment centers in the nation. Our multispecialty team provides comprehensive and individualized treatment plans for patients with myelodysplastic syndrome and acute myeloid leukemia.Â
Latest Myelodysplastic Syndrome Treatments
At Moffitt, our malignant hematology team provides an extensive range of treatment options for myelodysplastic syndrome. In most cases, patients receive a series of high-dose chemotherapy followed by a stem cell or bone marrow transplant. The exact treatment plan will depend on the patient’s unique diagnosis. Options may include one of a combination of the following MDS therapies:
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Stem cell and bone marrow transplantsÂ
- Blood transfusionsÂ
Our multispeciality team can also match patients with active clinical trials in which the effectiveness of innovative treatments is compared to that of existing therapies.
Supportive and Emotional Care
Myelodysplastic syndrome patients have full access to a range of supportive care in the same location as their treatment. These services, some of which are also available to caregivers, include:
- Psychosocial counseling
- Side effect management
- Dietary advice
- Support groups
- Chaplaincy and spiritual care
Why Myelodysplastic Syndrome Patients Choose Moffitt
As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt is at the forefront of myelodysplastic syndrome treatment. This distinction speaks of our commitment to cancer research and our robust clinical trial program, aimed at discovering new, innovative treatments for MDS among other cancers.
Traveling to MoffittÂ
Patients and their caregivers who are traveling from throughout Florida for MDS treatment have access to overnight lodging if needed. Moffitt has partnered with nearby hotels that provide discounted rates and shuttle service to and from Moffitt.
We also have several locations throughout the Tampa Bay area that offer some flexibility with scheduling, in addition to established partnerships with Memorial Healthcare System and AdventHealth.
Virtual VisitsÂ
Virtually scheduled visits from the comfort of your own home may be an option for follow-up appointments, pre-visit information sessions, medication review and more. Your treatment team can explain your options.Â
To discuss an MDS diagnosis or treatment options with the malignant hematology team at Moffitt, call 1-888-663-3488Â or complete a new patient registration form. We provide every new patient access to a cancer expert within one day.Â
Myelodysplastic Syndromes (MDS)
- Acute Lymphocytic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia (APL)
- Adenocarcinoma
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Brain Metastases
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Chronic Lymphocytic Leukemia (CLL)
- Colon Cancer
- Colorectal Cancer
- Chronic Myeloid Leukemia (CML)
- Cutaneous Lymphoma (CTCL)
- Diffuse Large B-Cell Lymphoma
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Follicular Lymphoma
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- Clinical Trials
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Mantle Cell Lymphoma
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Non-Small Cell Lung Cancer
- Oral Cavity (Mouth) Cancer
- Insurance and Financial Information
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Small Cell Lung Cancer
- Smoldering Multiple Myeloma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer